Becker's Healthcare August 18, 2022
New York City-based Mount Sinai Health System has started a gene-sequencing program that will be one of the largest of its kind.
The project aims to enroll a racially and ethnically diverse group of about a million Mount Sinai patients over the next five years to give researchers an extensive dataset to develop targeted treatments and new therapies.
“At Mount Sinai, precision medicine rests on a three-legged stool of gene sequencing, advanced electronic medical records and cutting-edge algorithmic data analysis techniques. This project exemplifies that highly promising approach,” Eric Nestler, MD, PhD, chief scientific officer at Mount Sinai, stated in an Aug. 12 health system news release.
Mount Sinai is partnering on the initiative with Icahn School of Medicine at...
Today's Sponsors
Today's Sponsor